Zomedica’s Dr. Bonnie Bragdon to Speak at AVMA Convention 2019 on Sunday, August 4
Novel Application of Technology in Diagnostic Testing will take place from 12:00 –
Additionally, Dr. Bragdon will discuss Novel Applications of Technology in Diagnostic Testing: How Cell Phones, Lasers, and Inkjet Printers Will Lead to Advances in Practice from 5:00 –
The session will cover topics including the use of Raman spectroscopy and bulk acoustic wave sensors in clinical diagnostics. Raman spectroscopy has been used commercially in drug production and biomedical research for decades. Dr. Bragdon will focus on Zomedica’s application of Raman spectroscopy in pathogen identification and antibiotic stewardship. Additionally, Dr. Bragdon will discuss how bulk acoustic wave sensors can improve immunoassay accuracy in veterinary medicine. Immunoassays are widely used in veterinary medicine to diagnose diseases. Bulk acoustic resonator technology is now cost-effective and can be used to drive improvements in immunoassay accuracy at the point-of-care. Currently, optical and electrical sensors are used, with limitations in performance, to measure binding events that provide results for clinical decision making.
Based in Ann Arbor, Michigan, Zomedica (NYSE American:
- Email Alerts: http://investors.zomedica.com
- LinkedIn: https://www.linkedin.com/company/zomedica
- Facebook: https://www.facebook.com/zomedica/
- Twitter: https://twitter.com/zomedica
Investor Relations Contact:
Shameze Rampertab, CPA, CA
Source: Zomedica Pharmaceuticals Corp.